Clinical Trials Logo

Healthy Postmenopausal Women clinical trials

View clinical trials related to Healthy Postmenopausal Women.

Filter by:
  • None
  • Page 1

NCT ID: NCT06467201 Not yet recruiting - Clinical trials for Healthy Postmenopausal Women

SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of KSHN001126 in Healthy Post-Menopausal Females

Start date: June 2024
Phase: Phase 1
Study type: Interventional

This is an Open-label, Sequential dosing, Single Ascending Dose (SAD) Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of KSHN001126 in Healthy Human Post-Menopausal Female Volunteers. The primary objective of the study is to evaluate the safety and tolerability of increasing single doses of KSHN001126 while the secondary objective is to evaluate the plasma PK profile of KSHN001126 and its metabolites (KSHN001167, KSHN001168 and Fulvestrant) following ascending single oral doses of KSHN001126.

NCT ID: NCT04000815 Completed - Clinical trials for Healthy Postmenopausal Women

Serum Levels of C Type Natriuretic Peptide in Different Reproductive Periods

CO
Start date: July 24, 2019
Phase: N/A
Study type: Interventional

Recent studies have shown that C natriuretic peptide (CNP) is produced from granulosa cells, increasing cumulative guanosine monophosphate (cGMP) production by affecting cumulus cells through natriuretic peptide receptors.It has been suggested that the transport of cGMP to oocyte via gap junctions causes a continuous increase in cyclic adenosine monophosphate (cAMP) levels within the oocyte. An important role of increased cAMP levels in oocyte is shown to suppress meiotic progression. Deoxyribonucleic acid (DNA) studies in animals have shown that expression of the natriuretic peptide precursor increases during the periovulatory period and shows that this increase decreases rapidly after Luteinizing hormone(LH) / human chorionic(hCG) stimulation. Human studies have shown that after ovulation induction, the CNP level in follicular fluid decreases following ovulatory dose of hCG (9).

NCT ID: NCT03065166 Completed - Clinical trials for Healthy, Postmenopausal Women

Dried Cabernet Grapes and Cardiovascular Risk Markers

RZN
Start date: September 2016
Phase: N/A
Study type: Interventional

This study assesses the acute effects of dried Cabernet grape intake on vascular function and platelet reactivity in postmenopausal women. Previous studies from this lab and others have demonstrated acute effects on vascular function and platelet reactivity from phenolic-rich food sources. Postmenopausal women are suggested as the study group, as they are likely to have compromised vascular function due to the loss of protective estrogen, and have been the study group for past and present research projects in this lab.

NCT ID: NCT02950402 Completed - Clinical trials for Healthy, Postmenopausal Women

Dried Plums and Chronic Disease Markers

Start date: June 2016
Phase: N/A
Study type: Interventional

This study evaluates whether the consumption of California dried plums can be beneficial to your health. Previous studies using dried plums have shown beneficial effects on bone and cardiovascular health. In addition the investigators hope to learn how dried plums might change your bowel habits, and if the carbohydrates in the plums are fermented in your digestive tract.

NCT ID: NCT01721993 Completed - Clinical trials for Healthy Postmenopausal Women

Open Label Dose Escalation Phase I Study to Investigate the Safety and Pharmacokinetics of T121E01F and T121E02F in Healthy Postmenopausal Women

Start date: January 2013
Phase: Phase 1
Study type: Interventional

THAR2011-1 is a Phase I, single dose, open-label dose-escalation study to determine the safety, absolute bioavailability, dose proportionality, and pharmacokinetics of T121 in healthy postmenopausal women. The study is expected to identify a safe dose that can be further tested in subsequent multiple dose studies comparing the safety, PK and pharmacodynamics (PD) of T121 with the currently marketed IV zoledronic acid (Zometa).

NCT ID: NCT01438073 Completed - Clinical trials for Hypogonadotropic Hypogonadism

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Start date: September 2011
Phase: Phase 1
Study type: Interventional

The investigators are looking for subjects to complete a study on the role of kisspeptin in the reproductive system. Kisspeptin is a naturally occurring hormone in humans that tells the body to produce other reproductive hormones. However, giving someone a continued amount of kisspeptin over a period of time can have the opposite effect and tell the body to, for a short time, stop making hormones needed for reproduction. By giving 24-hour infusions of kisspeptin, the investigators hope to learn more about the role kisspeptin has in the way bodies function normally and the role it has in conditions that affect the reproductive system.